Cancer Family
Nervous System Neoplasm
CI-CAN-00000038Explore in graph →
Non-malignant1,523 active trials9 approved drugs210 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000038Explore in graph →
Clinical trials
5,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06499831 | 18F-FET-PET/MRI vs Standard MRI Alone for Stereotactic RadioTherapy Planning for High Grade Brain Gliomas(FETSMaRT) | unknown | N/A | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | May 25, 2025 | clinicaltrials |
| NCT01903330 | ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme | unknown | Phase 2 | 84 | Epitopoietic Research CorporationINDUSTRY | 1 | Mar 5, 2025 |
| NCT06828341 | A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 Expression | unknown | Early Phase 1 | 3 | JIANG LONGWEIOTHER | 1 | Feb 14, 2025 | clinicaltrials |
| NCT06684795 | FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06585527 | Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma | unknown | Phase 1 | 30 | Beijing Neurosurgical InstituteOTHER | 1 | Oct 31, 2024 | clinicaltrials |
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | unknown | Phase 1 / Phase 2 | 179 | NGM Biopharmaceuticals, IncINDUSTRY | 3 | Oct 2, 2024 | clinicaltrials |
| NCT05106725 | Wearable Devices and Biomarkers Project (Healthiomics) | unknown | — | 3,500 | CureScienceOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05689112 | Microscopy Imaging of Whole-mount Stained Human Tissues | unknown | — | 250 | National Taiwan University HospitalOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06042946 | Microsurgical Resection of Intramedullary Spinal Cord Metastases | unknown | — | 60 | Cantonal Hospital of St. GallenOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT06559566 | Evaluation of Postoperative Intracranial Pressure in Patients Undergoing Intracranial Tumor Surgery | unknown | N/A | 50 | Sezen Kumaş SolakOTHER_GOV | 0 | Aug 19, 2024 | clinicaltrials |
| NCT06029140 | Stereotactic Radiotherapy Management of Brain Metastases: the Value of a Longitudinal Multimodal Approach (POSTPONE)(POSTPONE) | unknown | — | 700 | University Hospital, BrestOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06157359 | Effect of SNB on the QoR in Patients Undergoing Supratentorial Tumor Resection | unknown | N/A | 84 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Aug 9, 2024 | clinicaltrials |
| NCT06353360 | TTField in Combination With Temozolomide and Tislelizumab in The Treatment of Newly Diagnosed Glioblastoma. | unknown | Phase 2 | 30 | Jiangsu Healthy Life Innovation Medical Technology Co., LtdINDUSTRY | 1 | Aug 9, 2024 | clinicaltrials |
| NCT03631953 | Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas(ALTREM) | unknown | Phase 1 | 25 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT06214689 | IDH1 and OCT4 in High Grade Astrocytoma | unknown | — | 35 | Assiut UniversityOTHER | 1 | Aug 6, 2024 | clinicaltrials |
| NCT04007185 | Surgically Induced Neurological Deficits in Glioblastomas (SIND Study)(SIND) | unknown | — | 52 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT06502210 | Identification of New Gene Spliceosomes in Neuroblastoma | unknown | — | 20 | Affiliated Hospital of Nantong UniversityOTHER | 1 | Jul 16, 2024 | clinicaltrials |
| NCT05618990 | OPTIMIZATION of ADVANCED MR SEQUENCES(OPT-IRM) | unknown | — | 300 | Centre Hospitalier St AnneOTHER | 1 | Jul 10, 2024 | clinicaltrials |
| NCT01638130 | Experiences and Needs of Patients With a High-grade Glioma and Their Caregivers | unknown | — | 30 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT04654975 | Metachronic Brain Metastases After Esophagectomy for Esophageal Cancer (METABREC)(METABREC) | unknown | — | 10,000 | Universitaire Ziekenhuizen KU LeuvenOTHER | 6 | Jul 3, 2024 | clinicaltrials |
| NCT04397978 | Local Ablative Therapy for Patients With Multiple (4-10) Brain Metastases(LAT-MUM) | unknown | — | 180 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jul 1, 2024 | clinicaltrials |
| NCT06472505 | Using Polyglycolic Acid Mesh Prevents Cerebrospinal Fluid Leakage | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Jun 25, 2024 | clinicaltrials |
| NCT06454097 | Study on Radiogenomics Features Associated With Radiochemotherapy Sensitivity in Gliomas | unknown | N/A | 200 | Beijing Tiantan HospitalOTHER | 1 | Jun 12, 2024 | clinicaltrials |
| NCT06445257 | A Clinical Study Evaluating the Safety and Efficacy of ZRMT Regimen in the Treatment of PCNSL | unknown | N/A | 30 | Huai'an First People's HospitalOTHER | 1 | Jun 6, 2024 | clinicaltrials |
| NCT05638451 | Sintilimab in Combination With Bevacizumab and Temozolomide in Recurrent Glioblastoma (GBM) Patients | unknown | Phase 2 | 30 | Zhujiang HospitalOTHER | 1 | Jun 5, 2024 | clinicaltrials |
| NCT06440122 | The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs) | unknown | — | 100 | King's College Hospital NHS TrustOTHER | 1 | Jun 3, 2024 | clinicaltrials |
| NCT06417372 | Intraoperative Fluorescent Staining Combined With Microsurgery for Gliomas | unknown | — | 100 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | May 16, 2024 | clinicaltrials |
| NCT06417658 | Comparing Cosmetic Outcomes: Endoscopic vs. Conventional Craniotomy for Frontal Skull Base Lesions | unknown | N/A | 42 | University of Health Sciences LahoreOTHER | 0 | May 16, 2024 | clinicaltrials |
| NCT02613988 | Advanced MR Imaging as Predictor of Treatment Response in Newly Diagnosed Glioblastomas | unknown | N/A | 100 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT05868928 | Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis | unknown | — | 132 | Asan Medical CenterOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT06412952 | 68Ga-NOTA-RM26 PET/CT in Glioma Patients | unknown | Early Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | May 14, 2024 | clinicaltrials |
| NCT04755920 | SGM-101 in Colorectal Brain Metastases.(SGM-CBM) | unknown | Phase 2 | 10 | Leiden University Medical CenterOTHER | 1 | May 9, 2024 | clinicaltrials |
| NCT06405256 | Magnetic Resonance Imaging-guided Adaptive Radiotherapy for Large Brain Metastases | unknown | — | 20 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT06395831 | Assessment of Quality of Life and Independence, as Well as Received Social Support for Spinal Cancer. | unknown | — | 100 | Andrzej Frycz Modrzewski Krakow UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT01538264 | Blood Flow MRI for Monitoring Brain Tumors(Glioma) | unknown | — | 125 | Beth Israel Deaconess Medical CenterOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06379230 | A Retrospective Study on Epidemiological Characteristics of Chinese NF1 Patients in Real World (PROMISE) | unknown | — | 2,000 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT00110110 | Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma | unknown | Phase 2 | 71 | The Hospital for Sick ChildrenOTHER | 4 | Apr 17, 2024 | clinicaltrials |
| NCT06330298 | Improving Social Cognition and Social Behaviour in Various Brain Disorders(T-ScEmo4ALL) | unknown | N/A | 84 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04600817 | A Study to Evaluate the Efficacy and Safety of TJ107 in Lympopenic Patients With Newly Diagnosed Glioblastoma Who Completed Standard Concurrent Chemoradiotherapy (CCRT) | unknown | Phase 2 | 160 | TJ Biopharma Co., Ltd.INDUSTRY | 2 | Apr 15, 2024 | clinicaltrials |
| NCT06363162 | Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery | unknown | N/A | 200 | Beijing Tiantan HospitalOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363201 | Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | unknown | N/A | 40 | Catalysis SLINDUSTRY | 1 | Apr 12, 2024 | clinicaltrials |
| NCT03741101 | Treatment of NF1-related Plexiform Neurofibroma With Trametinib(plexifpc) | unknown | Phase 2 | 15 | Region SkaneOTHER | 1 | Apr 11, 2024 | clinicaltrials |
| NCT01906814 | Adjuvant Chemotherapy for High-risk Retinoblastoma After Enucleation | unknown | Phase 3 | 179 | Sun Yat-sen UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT04573192 | A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression(GLIOSTAR) | unknown | Phase 1 / Phase 2 | 142 | Philogen S.p.A.INDUSTRY | 4 | Apr 8, 2024 | clinicaltrials |
| NCT06348693 | Development of Therapeutic Approaches Modulating Molecular Targets Implicated on Cancer Stem Cell-related Aggressiveness | unknown | — | 400 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03548571 | Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy(DEN-STEM) | unknown | Phase 2 / Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05043701 | Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma(ISM-GBM) | unknown | Early Phase 1 | 15 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06318065 | Surgical Resection Outcomes in Patients With Brain Metastasis | unknown | — | 100 | National Cheng-Kung University HospitalOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT06156020 | Outcome Analysis of Endoscopic Resection of Pituitary Adenomas | unknown | N/A | 500 | National Cheng-Kung University HospitalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT04163419 | Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | unknown | Phase 2 | 9 | Massachusetts General HospitalOTHER | 1 | Mar 13, 2024 | clinicaltrials |
Data updated 22 days agoSource updated May 25, 2025source: clinicaltrials